![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
|
|
|
17th European AIDS Conference, November 6-9, 2019, Basel
Reported by Jules Levin
M Ait-Khaled,1 M-C Nascimento,1 KA Pappa,2 R Wang,2 J Wright,3 AR Tenorio,2 B Wynne,2
M Aboud,1 MJ Gartland,2 J van Wyk1
1ViiV Healthcare, Brentford, UK; 2ViiV Healthcare, Research Triangle Park, NC, USA; 3GlaxoSmithKline, Stockley Park, UK
![1107191](../images/110719/110719-4/1107191.gif)
![1107192](../images/110719/110719-4/1107192.gif)
![1107193](../images/110719/110719-4/1107193.gif)
![1107194](../images/110719/110719-4/1107194.gif)
![1107195](../images/110719/110719-4/1107195.gif)
![1107196](../images/110719/110719-4/1107196.gif)
![1107197](../images/110719/110719-4/1107197.gif)
![1107198](../images/110719/110719-4/1107198.gif)
![1107199](../images/110719/110719-4/1107199.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|